Cargando…
Twist2 amplification in rhabdomyosarcoma represses myogenesis and promotes oncogenesis by redirecting MyoD DNA binding
Rhabdomyosarcoma (RMS) is an aggressive pediatric cancer composed of myoblast-like cells. Recently, we discovered a unique muscle progenitor marked by the expression of the Twist2 transcription factor. Genomic analyses of 258 RMS patient tumors uncovered prevalent copy number amplification events an...
Autores principales: | Li, Stephen, Chen, Kenian, Zhang, Yichi, Barnes, Spencer D., Jaichander, Priscilla, Zheng, Yanbin, Hassan, Mohammed, Malladi, Venkat S., Skapek, Stephen X., Xu, Lin, Bassel-Duby, Rhonda, Olson, Eric N., Liu, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546057/ https://www.ncbi.nlm.nih.gov/pubmed/30975722 http://dx.doi.org/10.1101/gad.324467.119 |
Ejemplares similares
-
TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma
por: Shah, Akansha M., et al.
Publicado: (2023) -
Disruption of the MyoD/p21 Pathway
in Rhabdomyosarcoma
por: Weintraub, Michael, et al.
Publicado: (1997) -
Sumoylation of histone deacetylase 1 regulates MyoD signaling during myogenesis
por: Joung, Hosouk, et al.
Publicado: (2018) -
Feedback regulation of Notch signaling and myogenesis connected by MyoD–Dll1 axis
por: Zhang, Haifeng, et al.
Publicado: (2021) -
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2021)